Nehal KS, Bichakjian CK. Update on Keratinocyte Carcinomas. N Engl J Med. 2018;379(4):363–74.

Article  CAS  PubMed  Google Scholar 

Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, Cavallo F, Giudice G, Stucci LS, Porta C, Tucci M. Non-melanoma skin cancers: biological and clinical features. Int J Mol Sci 2020;21(15):5394.

Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, Dreno B, ConcettaFargnoli M, Forsea AM, Frenard C, Harwood CA, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NWJ, Malvehy J, Del Marmol V, Middleton MR, Moreno-Ramirez D, Pellecani G, Peris K, Saiag P, van den Beuken-van Everdingen MHJ, Vieira R, Zalaudek I, Eggermont AMM, Grob JJ. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treat Eur J Cancer. 2020;128:83–102.

Article  CAS  PubMed  Google Scholar 

Frei E 3rd. Clinical cancer research: an embattled species. Cancer. 1982;50(10):1979–92.

Article  PubMed  Google Scholar 

Roy P, Barbara K, Herbert S, Reinhold B. Photodynamic therapy with ALA: a clinical handbook. Royal Society of Chemistry. 2006.

Kato H, Konaka C, Ono J, Kawate N, Nishimiya K, Shinohara H, Saito M, Sakai H, Noguchi M, Kito T, et al. Preoperative laser photodynamic therapy in combination with operation in lung cancer. J Thorac Cardiovasc Surg. 1985;90(3):420–9.

Article  CAS  PubMed  Google Scholar 

Jeremic G, Moore CC, Brandt MG, Doyle PC. Neoadjuvant use of photodynamic therapy in Basal cell and squamous cell carcinomas of the face. ISRN dermatology. 2011;2011: 809409.

Article  PubMed  PubMed Central  Google Scholar 

Frei E 3rd. What’s in a name–neoadjuvant. J Natl Cancer Inst. 1988;80(14):1088–9.

Article  PubMed  Google Scholar 

Gross ND, Miller DM, Khushalani NI, Divi V, Ruiz ES, Lipson EJ, Meier F, Su YB, Swiecicki PL, Atlas J, Geiger JL, Hauschild A, Choe JH, Hughes BGM, Schadendorf D, Patel VA, Homsi J, Taube JM, Lim AM, Ferrarotto R, Kaufman HL, Seebach F, Lowy I, Yoo SY, Mathias M, Fenech K, Han H, Fury MG, Rischin D. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. N Engl J Med. 2022;387(17):1557–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature. 2022;611(7934):155–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gross ND, Miller DM, Khushalani NI, Divi V, Ruiz ES, Lipson EJ, Meier F, Su YB, Swiecicki PL, Atlas J, Geiger JL, Hauschild A, Choe JH, Hughes BGM, Schadendorf D, Patel VA, Homsi J, Taube JM, Lim AM, Ferrarotto R, Yoo SY, Mathias M, Han H, Seebach F, Lowy I, Fury MG, Rischin D. Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study. Lancet Oncol. 2023;24(11):1196–205.

Article  CAS  PubMed  Google Scholar 

Seth R, Agarwala SS, Messersmith H, Alluri KC, Ascierto PA, Atkins MB, Bollin K, Chacon M, Davis N, Faries MB, Funchain P, Gold JS, Guild S, Gyorki DE, Kaur V, Khushalani NI, Kirkwood JM, McQuade JL, Meyers MO, Provenzano A, Robert C, Santinami M, Sehdev A, Sondak VK, Spurrier G, Swami U, Truong TG, Tsai KK, van Akkooi A, Weber J. Systemic Therapy for Melanoma: ASCO Guideline Update, Journal of clinical oncology : official journal of the American Society of. Clin Oncol. 2023;41(30):4794–820.

CAS  Google Scholar 

Swetter SM, Thompson JA, Albertini MR, Barker CA, Baumgartner J, Boland G, Chmielowski B, DiMaio D, Durham A, Fields RC, Fleming MD, Galan A, Gastman B, Grossmann K, Guild S, Holder A, Johnson D, Joseph RW, Karakousis G, Kendra K, Lange JR, Lanning R, Margolin K, Olszanski AJ, Ott PA, Ross MI, Salama AK, Sharma R, Skitzki J, Sosman J, Wuthrick E, McMillian NR, Engh AM. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021. J Nat Compr Cancer Netw: JNCCN. 2021;19(4):364–76.

Article  Google Scholar 

Akopov A, Rusanov A, Gerasin A, Kazakov N, Urtenova M, Chistyakov I. Preoperative endobronchial photodynamic therapy improves resectability in initially irresectable (inoperable) locally advanced non small cell lung cancer. Photodiagn Photodyn Ther. 2014;11(3):259–64.

Article  Google Scholar 

Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer. 2003;97(11):2783–90.

Article  PubMed  Google Scholar 

Berr F, Tannapfel A, Lamesch P, Pahernik S, Wiedmann M, Halm U, Goetz AE, Mössner J, Hauss J. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol. 2000;32(2):352–7.

Article  CAS  PubMed  Google Scholar 

Allison RR, Zervos E, Sibata CH. Cholangiocarcinoma: an emerging indication for photodynamic therapy. Photodiagn Photodyn Ther. 2009;6(2):84–92.

Article  CAS  Google Scholar 

Niebel D, Sirokay J, Hoffmann F, Fröhlich A, Bieber T, Landsberg J. Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic Directions. Dermatology and therapy. 2020;10(4):835–46.

Article  PubMed  PubMed Central  Google Scholar 

Salido-Vallejo R, Cuevas-Asencio I, Garnacho-Sucedo G, González-Menchen A, Alcántara-Reifs C, De la Corte-Sánchez S, Vélez A, Moreno-Giménez JC. Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV. 2016;30(7):1120–4.

Article  CAS  PubMed  Google Scholar 

Reigneau M, Robert C, Routier E, Mamelle G, Moya-Plana A, Tomasic G, Mateus C. Efficacy of neoadjuvant cetuximab alone or with platinum salt for the treatment of unresectable advanced nonmetastatic cutaneous squamous cell carcinomas. Br J Dermatol. 2015;173(2):527–34.

Article  CAS  PubMed  Google Scholar 

Jenni D, Karpova MB, Mühleisen B, Mangana J, Dreier J, Hafner J, Dummer R. A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis. ESMO open. 2016;1(1): e000003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferrarotto R, Amit M, Nagarajan P, Rubin ML, Yuan Y, Bell D, El-Naggar AK, Johnson JM, Morrison WH, Rosenthal DI, Glisson BS, Johnson FM, Lu C, Mott FE, Esmaeli B, Diaz EM Jr, Gidley PW, Goepfert RP, Lewis CM, Weber RS, Wargo JA, Basu S, Duan F, Yadav SS, Sharma P, Allison JP, Myers JN, Gross ND. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, Clinical cancer research : an official journal of the American Association for. Can Res. 2021;27(16):4557–65.

CAS  Google Scholar 

Gellrich FF, Hüning S, Beissert S, Eigentler T, Stockfleth E, Gutzmer R, Meier F. Medical treatment of advanced cutaneous squamous-cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019;33(Suppl 8):38–43.

Article  PubMed  Google Scholar 

Sekulic A, Migden MR, Lewis K, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Dirix L, Hou J, Yue H, Hauschild A. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol. 2015;72(6):1021-6.e8.

Article  PubMed  Google Scholar 

Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer. 2017;17(1):332.

Article  PubMed  PubMed Central  Google Scholar 

Basset-Séguin N, Hauschild A, Kunstfeld R, Grob J, Dréno B, Mortier L, Ascierto PA, Licitra L, Dutriaux C, Thomas L, Meyer N, Guillot B, Dummer R, Arenberger P, Fife K, Raimundo A, Dika E, Dimier N, Fittipaldo A, Xynos I, Hansson J. Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial, European journal of cancer (Oxford. England. 1990;86(2017):334–48.

Google Scholar 

Bertrand N, Guerreschi P, Basset-Seguin N, Saiag P, Dupuy A, Dalac-Rat S, Dziwniel V, Depoortère C, Duhamel A, Mortier L. Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma. EClinicalMedicine. 2021;35: 100844.

Article  PubMed  PubMed Central  Google Scholar 

Lai M, Pampena R, Mirra M, Raucci M, Benati E, Borsari S, Lombardi M, Banzi M, Castagnetti F, Palmieri T, Piana S, Ramundo D, Pellacani G, Longo C. Characteristics and management of skin cancers in very elderly patients: A real-world challenge for clinicians. Exp Dermatol. 2022;31(10):1554–62.

Article  CAS  PubMed  Google Scholar 

Shiratori M, Ozawa T, Ito N, Awazu K, Tsuruta D. Open study of photodynamic therapy for skin ulcers infected with MRSA and Pseudomonas aeruginosa. Photodiagn Photodyn Ther. 2021;36: 102484.

Article  CAS  Google Scholar 

Ji J, Zhang Y, Chen WR, Wang X. DC vaccine generated by ALA-PDT-induced immunogenic apoptotic cells for skin squamous cell carcinoma. Oncoimmunology. 2016;5(6): e1072674.

Article  PubMed  Google Scholar 

• Zeng Q, Yang J, Ji J, Wang P, Zhang L, Yan G, Wu Y, Chen Q, Liu J, Zhang G, Wang X. PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma. Oncoimmunology. 2022;11(1):2061396. This reference is of importance because it confrmed that ALA-PDT could recruit tertiary lymphoid structure (TLS)-like intratumoral lymphoid aggregates in cutaneous squamous cell carcinoma, and enhance anti-tumor immunity.

Article  PubMed  PubMed Central  Google Scholar 

Wu YH, Wu F, Yan GR, Zeng QY, Jia N, Zheng Z, Fang S, Liu YQ, Zhang GL, Wang XL. Features and clinical significance of tertiary lymphoid structure in cutaneous squamous cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV. 2022;36(11):2043–50.

Article  CAS  PubMed  Google Scholar 

• Yang W, Liu L, Yang W, Wang D. Surgery combined with photodynamic therapy versus surgery alone for the treatment of non-melanoma skin cancer and actinic keratosis: A retrospective cohort study. Dermatol Ther. 2022;35(8): e15652. This reference is of importance because its an retrospective cohort study included 125 patients of NMSC or actinic keratosis to compared the recurrence-free survival rates between surgery alone and surgery with postoperative PDT. Though there is no significant differences between groups, adjuvant or neoadjuvant PDT could be taken into considering with other advantages and disadvantages.

Article  CAS  PubMed  Google Scholar 

Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, Bataille V, Marmol VD, Dummer R, Harwood CA, Hauschild A, Höller C, Haedersdal M, Malvehy J, Middleton MR, Morton CA, Nagore E, Stratigos AJ, Szeimies RM, Tagliaferri L, Trakatelli M, Zalaudek I, Eggermont A, Grob JJ. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines, European journal of cancer (Oxford. England. 1990;118(2019):10–34.